Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Therapeutic efficacy of a nove...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.
Bibliographic Details
Main Authors:
Rupniak, N
,
Tye, S
,
Jennings, C
,
Loper, A
,
Bondi, J
,
Hichens, M
,
Iversen, S
,
Stahl, S
Format:
Journal article
Language:
English
Published:
1989
Holdings
Description
Similar Items
Staff View
Similar Items
Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.
by: Rupniak, N, et al.
Published: (1989)
(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
by: Rupniak, N, et al.
Published: (1990)
CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
by: Boyce, S, et al.
Published: (1990)
NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys.
by: Tye, S, et al.
Published: (1989)
Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys.
by: Boyce, S, et al.
Published: (1990)